Expandable spinal implants are changing how surgeons approach spinal fusion, particularly in minimally invasive procedures. Unlike static cages, which retain a fixed shape, expandable implants can be inserted in a compact configuration and enlarged after positioning. Depending on the design, they can also adjust their height and angle to support spinal alignment.
For medical device companies, innovation extends beyond developing an implant that expands. Improvements in expansion mechanisms, movement control, implant geometry, surgical instruments and structural stability can all contribute to product differentiation. Understanding these developments helps innovators identify technical advances that may warrant patent protection.
How Expandable Spinal Implants Work
Expandable interbody cages are placed between vertebrae to provide structural support while spinal fusion develops. In minimally invasive transforaminal lumbar interbody fusion (MI-TLIF), the implant must pass through a restricted surgical corridor before reaching the disc space.
A static cage enters at its final dimensions, whereas an expandable cage can be introduced at a lower profile and enlarged after positioning. Depending on the device, this can provide flexibility in implant placement and the restoration of disc height.
A 2024 review identified five principal mechanical approaches used in expandable spinal devices: screw, scissor, ratchet, insertion-expansion and pneumatic mechanisms. Their applications differ, and pneumatic mechanisms are more commonly associated with vertebral augmentation procedures than conventional interbody cages.
The distinction matters for product development. The general concept of an expandable implant is established, so potential differentiation may lie in the specific mechanism, component arrangement or method of controlling movement.
| Technology component | What it does and why it matters | Patent insight |
| Expansion mechanism | Changes implant dimensions after insertion | Distinctive mechanical arrangements or movement mechanisms may present opportunities for protection |
| Actuation and control | Transmits input to the components responsible for expansion | New ways of engaging or coordinating moving components may be technically significant |
| Implant geometry | Determines the final height, angle and supporting footprint | Novel structural configurations or methods of achieving adjustable geometry may warrant evaluation |
| Position retention | Helps maintain the selected configuration under load | Improvements to locking, engagement or resistance to unintended movement may represent protectable advances |
| Surgical instruments | Position the implant and control deployment | Instrument mechanisms and implant-instrument interfaces can provide additional areas for innovation |
These areas may overlap, but they do not automatically constitute one invention. Identifying the specific technical contribution is an important step in assessing patentability and planning appropriate protection.
1. Expansion Mechanisms: Turning Movement into Controlled Deployment
Expandable cages use different mechanical principles to move from their insertion configuration to their deployed form.
Screw-driven mechanisms convert rotation into movement through threaded components. Scissor mechanisms use linked components and pivots to separate supporting surfaces. Ratchet systems use engagement features to advance or retain movement, while insertion-expansion designs connect deployment to the insertion process.
Each approach involves different constraints involving available space, movement control, structural support and mechanical complexity. The challenge is to achieve the intended expansion while preserving the implant’s ability to support the vertebrae.
For developers, these engineering trade-offs can define the focus of an invention. A new design might simplify the arrangement of moving components, improve the transmission of input or change how the mechanism operates during deployment.
The relevant question is not simply whether a cage expands, but what is technically distinctive about the way it does so. Reviewing existing patents and other technical disclosures can help innovators understand the existing approaches and assess whether a proposed mechanism offers a potentially novel contribution. A patent search alone, however, does not establish patentability or freedom to operate.
2. Multi-Axis Expansion: Controlling Height and Angle
Some expandable cages increase their height relatively uniformly. Others allow the anterior and posterior ends to move independently, changing both the implant’s height and the angle between its supporting surfaces.
This capability can help surgeons adjust implant geometry to the intended spinal alignment. However, greater adjustability introduces additional engineering considerations: the mechanism must provide the intended movement while remaining sufficiently stable and reliable.
A 2025 systematic review initially identified 387 articles and included 49 studies of expandable interbody cages. Outcomes varied with implant design, surgical approach and implant location. Certain rectangular titanium cages offering medial-lateral and vertical expansion, together with continuous lordotic adjustment, were associated with improved patient-reported outcomes. These findings do not establish that all multidirectional designs produce better clinical results.
A specific example of the engineering involved is Globus Medical’s US Patent No. 12,440,351 B2, granted on October 14, 2025. The patent describes an expandable interbody implant and a driver with two independently rotatable, coaxial shafts. A reversible driver key selects different interactions between the drive components, enabling parallel or differential expansion configurations.
The example illustrates how innovation can extend beyond the resulting implant geometry to the mechanism used to select and produce that movement.
Developers working on adjustable implants should identify whether their contribution lies in the geometry itself, the mechanism enabling independent movement or the system used to control it. These are distinct technical aspects that may require different approaches to protection, depending on the existing patent record and the specific invention.
3. Implant Geometry: Balancing Expansion and Structural Support
An expandable cage’s final geometry influences how it occupies the disc space and contacts the vertebral endplates. Three considerations are particularly relevant:
- Height: The distance between the upper and lower supporting surfaces.
- Lordotic angle: The angle between those surfaces, which can influence spinal alignment.
- Footprint and contact geometry: The area and distribution of contact with the supporting bone.
These characteristics interact. A design offering a wider expansion range must still accommodate the structural demands placed on the implant. The final configuration, rather than maximum expansion alone, is important to its intended function.
For medical device innovators, this creates opportunities to investigate new combinations of shape, movement and support. A design might improve how an implant adjusts its angle or achieve a required configuration within a compact structure.
A change in dimensions or shape does not automatically establish patentability. Innovators should document the technical problem, how the design addresses it and what distinguishes the proposed solution from existing disclosures. This can help identify meaningful technical contributions rather than routine design modifications. Whether a particular contribution qualifies for a patent depends on the applicable legal requirements, including novelty and inventive step.
4. Surgical Instruments: An Additional Area of Innovation
An expandable cage depends on its surgical instrument for positioning, engagement and controlled deployment. The instrument must transmit the required input, engage the appropriate components and allow the implant to reach its intended configuration.
The dual-shaft driver described in Globus Medical’s US Patent No. 12,440,351 B2 illustrates this relationship. Its independently rotatable shafts and reversible key provide different drive interactions within a compact instrument. The instrument’s architecture therefore contributes to how the implant achieves its intended movement.
This relationship creates opportunities to improve both the implant and the tools used to operate it.
| Development area | Practical purpose | Potential patent opportunity |
| Implant interface | Connects the instrument to the implant | Distinctive engagement or coupling arrangements |
| Drive mechanism | Transmits input to expansion components | New ways of delivering or coordinating movement |
| Selective actuation | Allows particular components to move independently | Mechanisms that control which components are actuated |
| Mode selection | Changes how the instrument operates | Features that select between deployment configurations |
| Integrated system | Coordinates the implant and instrument | Technical interactions that enable a distinct function |
Focusing exclusively on the implant body may overlook other relevant developments. Considering the complete product system can help identify potentially protectable instrument features and component interactions. Related inventions may also need to be evaluated in the context of existing third-party rights.
5. Mechanical Reliability: Maintaining the Expanded Configuration
The implant’s engineering requirements extend beyond successful deployment. Its structure must support the intended load, retain its configuration and function as designed while fusion develops.
A 2025 study analysed 821 reports involving expandable lumbar interbody cages submitted to the US Food and Drug Administration’s Manufacturer and User Facility Device Experience (MAUDE) database between January 2013 and July 2023.
The most frequently reported issue categories were cage breakage during insertion (25.7%), postoperative migration without collapse (16.0%), postoperative collapse (15.6%) and inserter breakage (11.1%). These percentages represent shares of the analysed reports, not complication rates among all patients or implanted devices. The database does not provide a reliable denominator for calculating incidence.
A separate FDA recall involving Medtronic’s Catalyft PL and PL40 expandable interbody systems was initiated in September 2025. The stated concern was that affected cages could lose height or collapse, potentially resulting in migration, subsidence or neurological injury. The corrective action involved updates to instructions for use and surgical guidance. This action relates to the specified devices and should not be interpreted as evidence that all expandable cages share the same risk.
These findings highlight the importance of evaluating the expansion mechanism, delivery instrument and deployed structure as connected elements.
Reliability challenges can guide technical development. A company may investigate an improved locking arrangement, a revised load-bearing structure or a different interaction between moving components. If the resulting solution is technically new and meets the relevant patentability requirements, it may warrant protection. Patent protection does not replace device testing, clinical evaluation or regulatory compliance.
6. What Clinical Evidence Means for Technology Development
Expandable implants offer additional control over insertion and final geometry, but that capability should not be confused with established clinical superiority across all outcomes.
A 2026 systematic review and meta-analysis in Global Spine Journal included 23 studies, 1,838 patients and 2,074 fused levels undergoing MI-TLIF. It reported pooled subsidence rates of 12.8% for expandable cages and 25.7% for static cages. However, only three studies directly compared the two cage types, and the analysis relied substantially on indirect comparisons. The authors also reported similar mean subsidence magnitudes when subsidence occurred: 5.33 mm for expandable cages and 4.54 mm for static cages.
The findings suggest an association between cage type and pooled subsidence rates, but they do not establish that expansion itself causes better outcomes. Differences in implant design, patient characteristics, surgical technique and study methodology must be considered.
For developers, clinical needs can help define meaningful engineering objectives. A new design might aim to improve positioning, restore disc height or maintain structural stability. Those objectives should be translated into measurable technical requirements and assessed through appropriate testing.
A desired clinical outcome alone is not a patentable invention. The potential contribution lies in the specific technical solution developed to address the underlying problem. Documenting the design, its intended function and the evidence supporting its performance can help inform patent drafting and IP planning.
Connecting Product Development with Patent Strategy
Expandable spinal implants demonstrate that innovation can occur across an interconnected system of mechanical components, implant geometry, actuation and surgical instrumentation. A meaningful advance may involve a new expansion mechanism, more controlled adjustment, an improved instrument interface or a structural change addressing a defined engineering limitation.
For medical device companies, the challenge is to recognise these contributions early enough to make informed decisions about protection. This involves documenting technical developments, reviewing relevant existing disclosures and considering which aspects of a product are genuinely distinctive.
Patentability and freedom to operate are separate considerations. Patentability assesses whether an invention qualifies for protection, while freedom to operate concerns whether a proposed product or activity may infringe enforceable third-party rights in relevant jurisdictions. Obtaining a patent on one feature does not establish freedom to operate for the complete device.
The objective is not to patent every component or design change. It is to identify the technical advances that distinguish a product, assess whether they qualify for protection and integrate those decisions into product development.
For expandable spinal implants, the opportunity lies in connecting better mechanical control with practical surgical needs while evaluating the underlying innovations for appropriate IP protection.
Sources
- https://pubmed.ncbi.nlm.nih.gov/38557229/
- https://doi.org/10.1080/17434440.2024.2337295
- https://pubmed.ncbi.nlm.nih.gov/39900249/
- https://doi.org/10.1016/j.spinee.2025.01.013
- https://patentsgazette.uspto.gov/week41/OG/html/1539-2/US12440351-20251014.html
- https://patents.google.com/patent/US20240366403A1/en
- https://pubmed.ncbi.nlm.nih.gov/39509577/
- https://doi.org/10.3928/01477447-20241104-02
- https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=216383
- https://pubmed.ncbi.nlm.nih.gov/42304724/
- https://doi.org/10.1177/21925682261460800
